פתיחת תפריט נגישות
גישה מהירה לדף הבית

אדמונית - Paeonia spp

עודכן בתאריך 10/08/2021

Peony - Bai shao / Chi shao / Mu dan pi


משפחה בוטנית: אדמוניתיים – Paeoniaceae

חלק הצמח | איכויות | רכיבים פעילים | התוויות | מינונים | רגישות | תופעות לוואי | 

מינון יתר | אזהרות | התוויות נגד | רעילות | אינטראקציות | הריון | הנקה

 

מונוגרף זה מתייחס לשלושת המינים הבאים:

P. lactiflora / Alba (שם עממי: White Peony), המוכר ברפואה הסינית תחת השם Bai shao (כאשר הקליפה קולפה מן השורש);

P. veitchii / Rubra (שם עממי: Red Peony / Veitch's peony), המוכר ברפואה הסינית תחת השם Chi shao (אם כי גם שורש P. lactiflora שאינו מקולף יכול לשמש כחומר גלם לתמצית זו);

P. suffruticosa (שם עממי: Chinese tree peony), המוכר ברפואה הסינית תחת השם Mu dan pi.

שם הסוג הבוטני נגזר משמו של Paeon, רופא האלים במיתולוגיה היוונית, שהיה תלמידו של אסקלפיוס (אל הרפואה). האגדה מספרת שאסקלפיוס קינא בתלמידו, וכדי להציל אותו מחרון אפו, זאוס הפך את פאון לצמח האדמונית.

שם המין lactiflora נובע מצבעם הלבן כחלב של עלי הכותרת; 

המין veitchii נקרא כך על שם משתלת ווייץ׳ (Veitch), ממנה נלקחה דגימה של הצמח.

הצבעים המוזכרים בשמות העממיים של המינים השונים מתייחסים לצבע השורש (עם או ללא קליפת הגזע) ולא לצבעי הפרחים.

אדמונית הינה צמח רב שנתי עשבוני. מוצאם של מיני האדמונית השונים הינו בסין.

מיני האדמונית השונים המוזכרים במונוגרף זה, מותרים לשיווק בישראל.

 

חלק הצמח בשימוש

שורש.

 

איכויות

טמפרטורה: קריר.

לחות: ניטראלי.

טעם: מריר, חמוץ, מתקתק.

 

רכיבים פעילים עיקריים

גליקוזידים מונוטרפניים (החשוב מביניהם הוא paeoniflorin, המהווה 0.05-6.01% מסך הצמח; oxypaeoniflorin, benzoylpaeoniflorin, albiflorin), טריטרפנים, פרואנתוציאנידינים, פלבונואידים, פנולים, טאנינים, פוליסכרידים, סטרולים, סידן (0.5-4%).

 

התוויות

כאבי מחזור (דיסמנוריאה), תסמונת קדם וסתית (PMS), אנדומטריוזיס, אל וסת (אמנוריאה), דימום וסתי מוגבר (מנורגיה), תסמונת גיל המעבר, אבנים בכיס המרה, דלקת בכיס המרה, מיומות, שחלות פוליציסטיות, דלקות כבד, מחלות מעי דלקתיות (IBD), קרוהן, קוליטיס,  כיב פפטי, תסמונת המעי הרגיש (IBS), כאבי ראש, מחלות אוטואימוניות, זאבת (לופוס), פיברומיאלגיה, תסמונת העייפות הכרונית (CFS), מחלת הסעיפים (דיברטיקולוזיס), דיכאון, אנמיה, בעיות פריון, דלקת מפרקים שגרונית (RA).

 

מינונים

תמצית נוזלית בריכוז 1:3, 45% אלכוהול – 10-25 מ״ל ביום.

תמצית יבשה – תלוי בריכוז התמצית. מינון המקביל ל- 3-12 גרם צמח ביום.

מרתח – 3-12 גרם ביום.

בפורמולה – 20-30%.

 

רגישות

לא ידועה רגישות מיוחדת לאדמונית.

 

תופעות לוואי

לא ידועות תופעות לוואי לשימוש באדמונית, למעט  למידע השלם למנויים

 

מינון יתר

לא ידוע על תופעות הנגרמות ממינון יתר של אדמונית.

 

אזהרות וצעדי מנע

יש לנקוט זהירות במתן אדמונית לאנשים הסובלים מ  למידע השלם למנויים

יש לנקוט זהירות במתן אדמונית (Chi shao) לאנשים הסובלים מ  למידע השלם למנויים

 

התוויות נגד

לא ידוע על התוויות נגד.

 

רעילות

לא נצפתה כל רעילות בשימוש באדמונית במינונים הרפואיים המקובלים.

בתנאי מעבדה, תמציות אדמונית  למידע השלם למנויים

מדד רעילותLD50:  למידע השלם למנויים

 

תגובות הדדיות עם תרופות צמחי מרפא תוספי תזונה

חילוף חומרים תרופתי

במחקרים קלינים(14,52) אדמונית לא השפיעה על הפעילות של אנזימיCYP2A6, CYP2C9, CYP2C19 , UGT וקשירת אלבומין. מחקרים פרה-קליניים (36,9,11,12,51) מראים תוצאות מעורבות בהקשר לאנזימים השונים כפי שמפורט להלן.

הרלוונטיות הקלינית של ממצאים אלו אינם ברורים.

תרופות אנטי-פסיכוטיות למידע השלם למנויים

תרופות נוגדות קרישה למידע השלם למנויים

תרופות DMARDs (למחלות אוטואימוניותלמידע השלם למנויים

סטרואידים למידע השלם למנויים

טיפול בשחפת למידע השלם למנויים

השריית ביוץ (clomiphene)  למידע השלם למנויים

התרופה Carbamazepine למידע השלם למנויים

התרופה Phenytoin למידע השלם למנויים

התרופה Midazolam למידע השלם למנויים

התרופה Losartan למידע השלם למנויים

התרופה Cetirizine (Zyrtec) למידע השלם למנויים

התרופה valproate למידע השלם למנויים

 אנטיביוטיקה למידע השלם למנויים

 למידע השלם למנויים Meloxicam

למידע השלם למנויים Cytarabine

 למידע השלם למנויים Cyclophosphamide 

למידע השלם למנויים Cisplatin

למידע השלם למנויים Carboplatin

למידע השלם למנויים Paclitaxel

צמחי מרפא ותוספי תזונה

 

הריון

מוטב להימנע משימוש באדמונית במהלך ההריון, במיוחד  למידע השלם למנויים

בחלק מהמחקרים שנערכו בבעלי חיים, נצפתה השפעה  למידע השלם למנויים

עם זאת, במחקר קליני לא מבוקר, אדמונית (לצד  למידע השלם למנויים

 

הנקה

חסר מידע בנושא.

 

 

מקורות

  1. מקורות

  2. Timmermans MW, Pentinga SE, Rustemeyer T, Bruynzeel DP. Contact dermatitis due to Paeonia (peony): a rare sensitizer? Contact Dermatitis. 2009 Apr;60(4):232-3. https://www.ncbi.nlm.nih.gov/pubmed/19338599
  3. Thorne Research, Inc. PEONY (PAEONIA SPP). Alternative Medicine Review, Volume 6, Number 5, 2001. p 495-499. https://altmedrev.com/wp-content/uploads/2019/02/v6-5-495.pdf
  4. Ahmad F, Tabassum N, Rasool S. Medicinal uses and phytoconstituents of Paeonia officinalis. IRJP 2012, 3:85-87. https://irjponline.com/admin/php/uploads/977_pdf.pdf
  5. Rayburn D. Let's Get Natural with Herbs. Huntsville: Ozark Mountain Publishing; 2007.
  6. European Medicines Agency (EMA). Assessment report on Paeonia lactiflora Pall. and/or Paeonia veitchii Lynch, radix (Paeoniae radix rubra). https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-paeonia-lactiflora-pall/paeonia-veitchii-lynch-radix-paeoniae-radix-rubra_en-0.pdf
  7. Bensky D, Gamble A, Kaptchuk T. Chinese Herbal Medicine Materia Medica. Vista, CA: Eastland Press, 1993. https://www.eastlandpress.com/products/eastland-herb
  8. Chang IM et al. Assay of potential mutagenicity and antimutagenicity of Chinese herbal drugs by using SOS Chromotest (E. coli PQ37) and SOS UMU test (S. typhimurium TA 1535/PSK 1002). Proceedings of the first Korea–Japan Toxicology Symposium, Safety Assessment of Chemicals in Vitro, 1989:133–145.
  9. Morimoto I et al. Mutagenicity screening of crude drugs with Bacillus subtilis recassay and Salmonella/microsome reversion assay. Mutation research, 1982, 97:81–102. https://www.ncbi.nlm.nih.gov/pubmed/6804865
  10. Chen LC, Chen YF, Chou MH, et al. Pharmacokinetic interactions between carbamazepine and the traditional Chinese medicine Paeoniae Radix. Biol Pharm Bull, 2002, 25:532–535. https://www.ncbi.nlm.nih.gov/pubmed/11995940
  11. Brewer CT, Chen T. Hepatotoxicity of Herbal Supplements Mediated by Modulation of Cytochrome P450. Int J Mol Sci. 2017 Nov 8;18(11). https://www.ncbi.nlm.nih.gov/pubmed/29117101
  12. Yu C., Chai X., Yu L., Chen S., Zeng S. Identification of novel pregnane X receptor activators from traditional chinese medicines. J. Ethnopharmacol. 2011;136:137–143. https://www.ncbi.nlm.nih.gov/pubmed/21524698
  13. Dong Y, Zhang Y, Yang Q, Li Y, Zhu X. [Absorption of extractive Radix Paeoniae Alba in rat everted gut sacs and its interaction with P-glycoprotein]. Zhongguo Zhong Yao Za Zhi. 2009 Apr;34(7):884-8. https://www.ncbi.nlm.nih.gov/pubmed/19623988
  14. Landmark CJ, Patsalos PN. Interactions between antiepileptic drugs and herbal medicines. Bol. Latinoam. Caribe Plant. Med. Aromaticas, 2008, Vol.7 (2). https://www.redalyc.org/pdf/856/85670209.pdf
  15. Chen LC; Chou MH, Lin MF, Yang LL. Lack of pharmacokinetic interaction between valproic acid and a traditional Chinese medicine, Paeoniae Radix. J Clin Pharm Ther, 2000, 25:453-459. https://pubmed.ncbi.nlm.nih.gov/11123499/
  16. Chen LC, Chou MH, Lin MF, Yang LL. Effects of Paeoniae Radix, a traditional Chinese medicine, on the pharmacokinetics of phenytoin. J Clin Pharm Ther 2001;26:271-8. https://www.ncbi.nlm.nih.gov/pubmed/11493369
  17. Wong AL, Chan TY. Interaction between warfarin and the herbal product quilinggao. Ann. Pharmacother, 2003, 37(6), 836- 838. https://www.ncbi.nlm.nih.gov/pubmed/12773074
  18. Wang Y, Ma R. Effect of an extract of Paeonia lactiflora on the blood coagulative and fibrinolytic enzymes. Chung Hsi I Chieh Ho Tsa Chih 1990;10:70, 101-2 [in Chinese]. https://www.ncbi.nlm.nih.gov/pubmed/2364461
  19. Xue JX, Jiang Y, Yan YQ. Effects of the combination of Astragalus membranaceus(Fisch.) Bge. (AM), root of Angelica sinensis (Oliv.) Diels. (TAS), Cyperus rotundus L. (CR), Ligusticum chuanxiong Hort. (LC) and Paeonia veitchii Lynch (PV) on the hemorrheological changes in normal rats. Chung Kuo Chung Yao Tsa Chih 1993; 18:621-3, 640 [in Chinese]. https://www.semanticscholar.org/paper/%5BEffects-of-the-combination-of-Astragalus-(Fisch.)-Xue-Jiang/13c488ac6d8d552B50d1afdf5c0c770240efec01
  20. Liu J. Effect of Paeonia obovata 801 on metabolism of thromboxane B2 and arachidonic acid and on platelet aggregation in patients with coronary heart disease and cerebral thrombosis. Chung Hua I Hsueh Tsa Chih (Chin Med J) 1983; 63:477-81 [in Chinese]. https://www.ncbi.nlm.nih.gov/pubmed/6418338
  21. Ngo T, et al. Antithrombotic Effects of Paeoniflorin from Paeonia suffruticosa by Selective Inhibition on Shear Stress-Induced Platelet Aggregation. Int J Mol Sci. 2019 Oct; 20(20): 5040. https://www.ncbi.nlm.nih.gov/pubmed/31614534
  22. Sung CK, Kang GH, Yoon SS, et al. Glycosidases that convert natural glycosides to bioactive compounds. Advances in experimental medicine and biology.404:23-26. 1996. https://www.researchgate.net/publication/14250926
  23. Man SC, et al. Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Women With Schizophrenia: A Randomized Controlled Trial. J Clin Psychopharmacol. 2016 Dec;36(6):572-579. https://www.ncbi.nlm.nih.gov/pubmed/27755159
  24. Yamada K, Kanba S, Murata T, Fukuzawa M, Terashi B, Yagi G, Asai M. Effectiveness of skakuyaku-kanzo-to in neuroleptic-induced hyperprolactinemia: a preliminary report. Psychiatr Clin Neurosci 1996;50:341-342. https://www.ncbi.nlm.nih.gov/pubmed/9014235
  25. Yuan HN, Wang CY, Sze CW, et al. A randomized, crossover comparison of herbal medicine and bromocriptine against resperidone-induced hyperprolactinemia in patients with schizophrenia. J Clin Psychopharmacol 2008; 28:264-70. https://www.ncbi.nlm.nih.gov/pubmed/18480682
  26. Yamada K, Kanba S, Yagi G, Asai M. Herbal medicine (skakuyaku-kanzo-to) in the treatment of risperidone-induced amenorrhea. J Clin Psychopharmacol 1999;19:380-381. https://www.ncbi.nlm.nih.gov/pubmed/10440470
  27. Yoshida T, Sawa T, Ishiguro T, et al. The efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following carboplatin and paclitaxel combination chemotherapy for non-small cell lung cancer. Support Care Cancer. 2009 Mar;17(3):315-20. https://www.ncbi.nlm.nih.gov/pubmed/18839222
  28. Xu JD, Liu ZH, Chen SZ. Effects of Paeonia-Glycyrrhiza decoction on changes induced by cisplatin in rats. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih 1994;14:673-674. [Article in Chinese]. https://www.ncbi.nlm.nih.gov/pubmed/7703638
  29. Jin L, Li C, Li Y, Wu B. Clinical Efficacy and Safety of Total Glucosides of Paeony for Primary Sjogren's Syndrome: A Systematic Review. Evid Based Complement Alternat Med, 2017, 3242301. https://www.ncbi.nlm.nih.gov/pubmed/28642798
  30. Chen Z, Li XP, Li ZJ, Xu L, Li XM. Reduced hepatotoxicity by total glucosides of paeony in combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis. Int Immunopharmacol. 2013 Mar;15(3):474-7. Epub 2013 Feb 12. https://www.ncbi.nlm.nih.gov/pubmed/23415907
  31. Zhang L, Wei W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther. 2020 Mar;207:107452. https://www.ncbi.nlm.nih.gov/pubmed/31836457
  32. Du JH, Dong BD. [Comparative study on clinical efficacy of using methotrexate singly or combined with total glucosides of Paeony in treating rheumatoid arthritis]. Chinese journal of integrated traditional and Western medicine 2005, 25(6):540-542 [Chinese] https://www.ncbi.nlm.nih.gov/pubmed/16025972
  33. Wang Y, Xing HY. [Clinical observation on effect of total glucosides of paeony combined with methotrexate on rheumatoid arthritis]. Chinese journal of integrated traditional and Western medicine 2007, 27(9):839-840 [Chinese] https://www.ncbi.nlm.nih.gov/pubmed/17969901
  34. Wang SL, Wang JP, Bian H. [Clinical observation on total glucosides of paeony combined with sulfasalazine in treatment of ankylosing spondylitis].
  35. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2007, 27, 217-219. https://www.ncbi.nlm.nih.gov/pubmed/17432680 Zhang HF, Xiao WG, Hou P. [Clinical study of total glucosides of paeony in patients with systemic lupus erythematosus]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2011, 31, 476-479. https://www.ncbi.nlm.nih.gov/pubmed/21608216
  36. Jiang RH, Xu HB, Fu J. Outcomes of Chinese herb medicine for the treatment of multidrug-resistant tuberculosis: a systematic review and meta-analysis. Complement Ther Med. 2015 Aug;23(4):544-54. Epub 2015 Jun 10. https://www.ncbi.nlm.nih.gov/pubmed/26275647
  37. Pao LH, Hu OY, Fan HY, et al. Herb–drug interaction of 50 Chinese herbal medicines on CYP3A4 activity in vitro and in vivo. Am J Chin Med, 2012, 40:57–73. https://www.ncbi.nlm.nih.gov/pubmed/22298448
  38. See CJ, McCulloch M, Smikle C, Gao J. Chinese herbal medicine and clomiphene citrate for anovulation: a meta-analysis of randomized controlled trials. J Altern Complement Med. 2011 May;17(5):397-405. https://www.ncbi.nlm.nih.gov/pubmed/21563919
  39. Jin Y, Qu C, Tang Y, Pang H, et al. Herb pairs containing Angelicae Sinensis Radix (Danggui): A review of bio-active constituents and compatibility effects. J Ethnopharmacol. 2016 Apr 2;181:158-71. https://www.ncbi.nlm.nih.gov/pubmed/26807913
  40. Yang ZY, Pei J, Liu RM, et al. [Study on enhancing bioavailability of paeoniflorin by combined use with Chinese herbs for inner-warming]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005;25(9):822–824. https://www.ncbi.nlm.nih.gov/pubmed/16248247
  41. Chen L, Hu C, Hood M, et al. An Integrated Approach Exploring the Synergistic Mechanism of Herbal Pairs in a Botanical Dietary Supplement: A Case Study of a Liver Protection Health Food. Int J Genomics. 2020 Apr 9;2020:9054192. https://www.ncbi.nlm.nih.gov/pubmed/32351982
  42. Brinker F. The Toxicology of Botanical Medicines, 3rd ed. Eclectic Medical Pub., Sandy, Ore., 2000. https://www.eclecticherb.com/the-toxicology-of-botanical-medicines/
  43. Brinker F. Herb Contraindications and Drug Interactions, 4th ed. Sandy (OR): Eclectic Medical Publications; 2010. https://www.eclecticherb.com/herb-contraindications-drug-interactions
  44. Farnsworth NR, Bingel AS, Cordell GA, et al. Potential value of plants as sources of new antifertility agents I. J. Pharm. Sci., 64:535-598, 1975. https://www.ncbi.nlm.nih.gov/pubmed/167146
  45. WHO. Radix Paeoniae. WHO Monographs on Selected Medicinal Plants. 1 vol. Geneva: World Health Organization; 1999:195-201. http://apps.who.int/medicinedocs/en/d/Js2200e/
  46. Woo WS et al. A review of research on plants for fertility regulation in Korea. Korean journal of pharmacognosy, 1981, 12:153–170. http://kpubs.org/article/articleMain.kpubs?articleANo=HKSOBF_1981_v12n3_153
  47. Hikino H. Oriental medicinal plants. In: Wagner H, Hikino H, Farnsworth NR, eds. Economic and medicinal plant research Vol. 1. London, Academic Press, 1985. https://jpharmsci.org/article/S0022-3549(15)47263-6/pdf
  48. Lee EB. The screening of biologically active plants in Korea using isolated organ preparation. IV. Anticholinergic and oxytocic actions in rat's ileum and uterus. Korean journal of pharmacognosy, 1982, 13:99–101. http://kpubs.org/article/articleMain.kpubs?articleANo=HKSOBF_1982_v13n3_99
  49. Harada M, Suzuki M, Ozaki Y. Effect of Japanese Angelica root and Paeonia root on uterine contraction in rabbit in situ. Journal of pharmacobiological dynamics, 1984, 7:304– 311. https://www.ncbi.nlm.nih.gov/pubmed/6470928.
  50. Guo TL, Zhou XW. Clinical observations on the treatment of the gestational hypertension syndrome with angelica and paeonia powder. Zhong Xi Yi Jie He Za Zhi. 1986 Dec;6(12):714-6, 707. [Article in Chinese]. https://www.ncbi.nlm.nih.gov/pubmed/2951019
  51. Youmna Ali, Tahiatul Shams, Ke Wang, et al. The involvement of human organic anion transporting polypeptides (OATPs) in drug-herb/food interactions. Chin Med. 2020 Jul 9;15:71. https://pubmed.ncbi.nlm.nih.gov/32670395/
  52. Iijima R, Watanabe T, Ishiuchi K, et al. Interactions between crude drug extracts used in Japanese traditional Kampo medicines and organic anion-transporting polypeptide 2B1. J Ethnopharmacol. 2018 Mar 25;214:153-159. https://pubmed.ncbi.nlm.nih.gov/29248449/
  53. Xie HJ, Yasar U, Sandberg M, Rane A. Paeoniae Radix, a traditional Chinese medicine, and CYP2C9 activity. J Clin Pharm Ther. 2002 Jun;27(3):229-30. https://pubmed.ncbi.nlm.nih.gov/12081638/
  54. Xu W, Zhou L, Ma X, et al. Therapeutic effects of combination of paeoniflorin and albiflorin from Paeonia radix on radiation and chemotherapy-induced myelosuppression in mice and rabbits. Asian Pac J Cancer Prev. 2011;12(8):2031-7. https://pubmed.ncbi.nlm.nih.gov/22292646/
  55. Zhu Q, Qi X, Wu Y, Wang K. Clinical study of total glucosides of paeony for the treatment of diabetic kidney disease in patients with diabetes mellitus. Int Urol Nephrol. 2016 Nov;48(11):1873-1880. https://pubmed.ncbi.nlm.nih.gov/27342654/
  56. Jiang H, Li J, Wang L, Wang S, et al. Total glucosides of paeony: A review of its phytochemistry, role in autoimmune diseases, and mechanisms of action. J Ethnopharmacol. 2020 Aug 10;258:112913. https://pubmed.ncbi.nlm.nih.gov/32371143/
  57. Zhou L, Cao T, Wang Y, Yao H, Du G, Tian Z, Tang G. Clinical observation on the treatment of oral lichen planus with total glucosides of paeony capsule combined with corticosteroids. Int Immunopharmacol. 2016 Jul;36:106-110. https://pubmed.ncbi.nlm.nih.gov/27129091/
  58. Long JW, Wang YY, Pi XM, Tu YT. Clinical observation on the treatment of chronic urticaria with total glucosides of paeony capsule combined with citirizine. Chin J Integr Med. 2010 Aug;16(4):353-6. https://pubmed.ncbi.nlm.nih.gov/20697948/
  59. Liu B, Meng X, Ma Y, et al. Clinical safety of total glucosides of paeony adjuvant therapy for rheumatoid arthritis treatment: a systematic review and meta-analysis. BMC Complement Med Ther. 2021 Mar 26;21(1):102. https://pubmed.ncbi.nlm.nih.gov/33771151/
  60. Feng Z, Zhang BQ, Zhu YM, et al. The effectiveness and safety of total glucosides of paeony in primary Sjogren's syndrome: a systematic review and meta-analysis. Front. Pharmacol. 2019, 10, 550. https://pubmed.ncbi.nlm.nih.gov/31178729/
  61. Feng ZT, Xu J, He GC, et al. A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of peony combined with methotrexate in rheumatoid arthritis. Clin Rheumatol. 2018 Jan;37(1):35-42. https://pubmed.ncbi.nlm.nih.gov/28748514/
  62. Huang Y, Wang H, Chen Z, et al. Efficacy and safety of total glucosides of paeony combined with methotrexate and leflunomide for active rheumatoid arthritis: a meta-analysis. Drug Des Devel Ther. 2019 Jun 17;13:1969-1984. https://pubmed.ncbi.nlm.nih.gov/31354242/
  63. Zheng Q, Jiang W, Sun X, et al. Total glucosides of paeony for the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials. Phytomedicine. 2019 Sep;62:152940. https://pubmed.ncbi.nlm.nih.gov/31100680/
  64. Lim JW, Chee SX, Wong WJ, He QL, Lau TC. Traditional Chinese medicine: herb-drug interactions with aspirin. Singapore Med J. 2018;59(5):230–9. https://www.ncbi.nlm.nih.gov/pubmed/29796686
  65. Zhao DD, Jiang LL, Li HY, Yan PF, Zhang YL. Chemical Components and Pharmacological Activities of Terpene Natural Products from the Genus Paeonia. Molecules. 2016 Oct 13;21(10):1362. https://pubmed.ncbi.nlm.nih.gov/27754383/
  66. Wu SH, Wu DG, Chen YW. Chemical constituents and bioactivities of plants from the genus Paeonia. Chem Biodivers. 2010 Jan;7(1):90-104. https://pubmed.ncbi.nlm.nih.gov/20087998/
  67. Koo YK, Kim JM, Koo JY, et al. Platelet anti-aggregatory and blood anti-coagulant effects of compounds isolated from Paeonia lactiflora and Paeonia suffruticosa. Pharmazie. 2010 Aug;65(8):624-8. https://pubmed.ncbi.nlm.nih.gov/20824965/
  68. Xie P, Cui L, Shan Y, Kang WY. Antithrombotic Effect and Mechanism of Radix Paeoniae Rubra. Biomed Res Int. 2017;2017:9475074. https://pubmed.ncbi.nlm.nih.gov/28299338/
  69. Qiu H, Zhang L, Zhu M, et al. Capture of anti-coagulant active ingredients from Moutan Cortex by platelet immobilized chromatography and evaluation of anticoagulant activity in rats. Biomed Pharmacother. 2017 Nov;95:235-244. https://pubmed.ncbi.nlm.nih.gov/28843912/
  70. Liapina LA, Ammosova IaM, Novikov VS, et al. [The nature of an anticoagulant isolated from peonies in the central zone of Russia]. Izv Akad Nauk Ser Biol. 1997 Mar-Apr;(2):235-7. https://pubmed.ncbi.nlm.nih.gov/9190224/
  71. Yang P, Li L, Yang D, Wang C, et al. Effect of Peony-Glycyrrhiza Decoction on Amisulpride-Induced Hyperprolactinemia in Women with Schizophrenia: A Preliminary Study. Evid Based Complement Alternat Med. 2017;2017:7901670. https://pubmed.ncbi.nlm.nih.gov/29317896/
  72. Feng FH, Zhang EZ. 42 cases of Sjogren’s syndrom treated by total glucosides of peony. Traditional Chinese Medicinal Research, vol. 21, no. 12, pp. 35–37, 2008.
  73. He H. Clinical investigation of Sjogren’s syndrome treated with total glucosides of peony alliance with hydroxychloroquine. Hubei Journal of Traditional Chinese Medicine, vol. 32, no. 11, pp. 30-31, 2008
  74. Cai WH. Clinical investigation of Sjogren’s syndrome treated with total glucosides of peony. Contemporary Medicine, vol. 17, no. 36, pp. 10-11, 2011.
  75. Yin B. Clinical investigation of Sjogren’s syndrome treated with total glucosides of peony alliance with hydroxychloroquine. World Chinese Journal of Digestology, vol. 12, no. 35, pp. 20-21, 2011.
  76. Lin XY, Chen RL, Zhu LX. Clinical observation on effect of total glucosides of paeony in treatment of primary Sjogren’s syndrome. Journal of Aesthetics and Cosmetology, vol. 4, no. 24, 328 pages, 2011.
  77. Zhao H, Zhao FT. Clinical study on treatment of primary Sjogren’s syndrome by total glucosides of paeony and hydroxychloroquine. Henan Traditional Chinese Medicine, vol. 33, no. 4, pp. 530-531, 2013.
  78. Liu Y, Deng H. Clinical investigation of Sjogren’s syndrome treated by total glucosides of peony alliance with methotrexate. Chinese Journal of General Practice, vol. 14, no. 2, pp. 230–231+278, 2016.
  79. Wang X, Zhuang M. Efficacy evaluation of total glucosides of paeoniae paeoniae combined with methotrexate in the treatment of rheumatoid arthritis. J China Prescription Drug. 2020;18(11):75–6.
  80. Guo X, Tan C. Clinical observation of total glucosides of paeoniae paeoniae combined with methotrexate in the treatment of rheumatoid arthritis. Med J Natl Defending Forces Southwest China. 2020;30(4):301–3
  81. Gong S. Clinical observation of total glucoseides of peony combined methotrexate on rheumatoid arthritis. Strait Pharm J. 2017;29(9):66–8.
  82. Chen Z, Liu Q, Liu J, Jiang X, Xue Y. Effect of total glucosides of paeony and methotrexate on refractory rheumatoid arthritis. Journal of Chinese practical diagnosis and therapy. J Chin Pract Diagn Ther. 2017;31(7):700–2.
  83. Lin W, Lin Q, Chen R. Effects observation of different treatment program in rheumatoid arthritis. China Modern Med. 2016;23(16):4–7.
  84. Wang X. Clinical observation of methotrexate combined with total glucosides of paeony for juvenile rheumatoid arthritis evaluation and analysis of drug-use in hospitals of China. Eval Anal Drug Use Hosp China. 2012;12(8):722–4.
  85. Sun Y. Comparative study on clinical efficacy of using methotrexate singly or combined with total glucosides of paeony in treating juvenile rheumatoid arthritis. J Taishan Med Coll. 2011;32(10):744–6.
  86. G S, Liu J. Comparative study on clinical efficacy of methotrexate combined with total glucosides of paeony in the treatment of rheumatoid arthritis. Chin J Clin Ration Drug Use. 2009;2(4):1–4
  87. Zhu J. Clinical analysis of methotrexate combined with total glucosides of paeony in treating rheumatoid arthritis. Shanxi J Tradit Chin Med, 2009, 25(sup):48–49
  88. Yin G, Xie Q. Clinical analysis of the efficacy of total glucosides of paeony capsules on rheumatoid arthritis. Modern Prev Med. 2007;34(19):3791–2. https://en.cnki.com.cn/Article_en/CJFDTotal-XDYF200719092.htm
  89. Liu Z. Therapeutic effect of Pavlin combined with methotrexate on rheumatoid arthritis. Chin J Pract Med. 2007:34(3):83–4.
  90. Fan Y, Li G. Study of total glucosides of paeony combined with low dosage methotrexate on elderly onset rheumatoid arthritis. Modern J Integr Tradit Chin Western Med. 2006;11:1440–2.
  91. Min W, Wei Q, Li H, Zhang Z, Wu L, Yuan G, Dou C, Shi G. A clinical study of total glucosides palony in the treatment of rheumatoid arthritis: a multicenter trial. Chin J Rheumatol. 2005;8:487–91.
  92. Han L, GUJANETHAN B, BAYAN E, Shi R, BAKHARGURI L, Wei R. Efficacy of leflunomide combined with total glucosides of peony in elderly patients with rheumatoid arthritis and its effects on ESR,CRP and RF. Chin J Hosp Pharm. 2016;36(7):568–71.
  93. Wu T, He R, Liu J, Li Y. The efficacy observation on leflunomide combine with total glucosides of paeony capsules for rheumatoid arthritis. Proc Clin Med. 2015;24(5):342–5
  94. Li M. The clinical efficacy of leflunomide combined with TGP in the treatment of elderly rheumatoid arthritis and its effect on C-reactive protein and erythrocyte sedimentation rate. China Foreign Med Treat. 2014;33(33):45–7
  95. Yu J, Zhang H. Clinical study of total glucosides of paeony combined with leflunomide in the treatment of active rheumatoid arthritis. Forum Tradit Chin Med. 2010;25(4):9–10
  96. Ma F. Efficacy and safety of total glucosides of paeony and leflunomide in the treatment of active RA. Liaoning J Tradit Chin Med. 2009;36(9):1509–10.
  97. Zhao Y, Liu Y. Clinical observation on effects of leflunomid and total glucosides of paeony on rheumatoid arthritis. Chin J Integr Tradit Western Med. 2006;26(4):355–7.https://pubmed.ncbi.nlm.nih.gov/16689008/
  98. Ju Y, Li R, Guo D, Feng X. Study on protective and adjuvant effect of total glucosides of paeoniae alba on liver function of rheumatoid arthritis. China Modern Doctor. 2019;57(30):34–7.
  99. Zhang H, Zhang W. Effect of combination of total glucosides of peony with methotrexate and leflunomide on follicular helper T cells. Acta Medica Mediterr. 2019;35:1239–44.
  100. Liu B. Leflunomide and total glucosides of paeoniae paeoniae combined with methotrexate therapy observation on therapeutic effect of rheumatoid arthritis. World Latest Med Inf (Electronic Version). 2019;19(44):134–6.
  101. Zhang X. Effect of combined treatment of total glucosides of paeony, methotrexate and leflunomide on WOMAC score in rheumatoid arthritis. Syst Med Pharmacol. 2019;4(6):75–7.
  102. Yu W, Xu J, Liang Y, Li M, Sha H. Clinical observation of total paeony glycoside capsule combined with methotrexate and leflunomide in the treatment of rheumatoid arthritis. Sichuan Med J. 2018;39(1):83–5.
  103. Tan K, Xiang Y, Yuan L, Dai Y. Clinical observation of total glucosides of paeoniae alba, methotrexate and leflunomide in the treatment of severe active rheumatoid arthritis. World Latest Med Inf. 2018; 18(6):159–64.
  104. Xu P. Clinical effect of total glucosides of paeonia paeoniae combined with methotrexate and leflunomide in the treatment of patients with rheumatoid arthritis. Med Pr. 2018;10:97–9.
  105. Yu H, Peng J, Ye X. Efficacy and safety of leflunomide and total glucosides of paeoniae paeoniae combined with methotrexate in the treatment of rheumatoid arthritis. Chin Med Innov. 2018;15(27):8–11.
  106. Zhang H, Fan H. Efficacy of total glucosides of paeonia on blood lipid in patients with rheumatoid arthritis. Chin J Clin Pharmacol. 2016;32(7):597–599.
  107. Wang Y. Therapeutic effect of two combined regimens on rheumatoid arthritis and comparison of liver damage. J Clin Med Lit. 2015;2(11):2132
  108. Wang Y. Effect of total glucosides of paeoniae paeoniae combined with immunosuppressant in the treatment of rheumatoid arthritis on liver function. Med Forum. 2012;16(13):1644–6.
  109. Wang Y, Li J, Li X. Comparison of efficacy and safety of Total Glucosides of Paeony combined with methotrexate and leflunomind in the treatment of rheumatoid arthritis. Natl Med Front China. 2011;6(19):16–7.
  110. Xiang N, Li XM, Zhang MJ, et al. Total glucosides of paeony can reduce the hepatotoxicity caused by methotrexate and Leflunomide combination treatment of active rheumatoid arthritis. Int Immunopharmacol. 2015;28(1):802–7. https://pubmed.ncbi.nlm.nih.gov/26292180/
  111. Zhang L, Zhou Y, Liu W. Clinical efficacy of total glucosides of paeony combined with tripterygium glycosides in the treatment of rheumatoid arthritis. Tianjin J Tradit Chin Med. 2005;3:207–8.
  112. Zhang C. Clinical observation on treating 90 cases of atrophic arthritis with meloxicam plus Total Glucosides of Paeony capsules. Clin J Chin Med. 2016; 8(4):86–7
  113. Huang Y. Clinical observation of treatment of rheumatoid arthritis with sulfasalazine and sulfasalazine combined with total glucosides of paeony. J Med Inform. 2014;27(5):419–20.
  114. Shen S. Clinical efficacy and safety observation of iguratimod combined with total glycosides of paeoniae paeoniae capsule in RA. Home Med. 2018; 2:160
  115. Li J. Clinical study of total glucosides of paeoniae paeoniae capsule combined with prednisone in the treatment of rheumatoid arthritis. Drugs Clin. 2020;35(4):748–51.
  116. You YQ, Wang WG. The clinical experience of Professor Wang Weigang in treating Sjögren’s syndrome and A preliminary explore of the clinical efficacy of total glucosides of paeony in the treatment of primary Sjögren’s syndrome. (dissertation/master’s thesis). Beijing University of Chinese Medicine, Beijing, China, 2015.
  117. Liu Y, Deng H. Clinical analysis of total glucosides of paeony combined with methotrexate in treatment of Sjogren syndrome. Chin. J. Gen. Practice 2016, 14, 230–231+278.
  118. Zhou Y, Jin L, Kong F, et al. Clinical and immunological consequences of total glucosides of paeony treatment in Sjögren's syndrome: A randomized controlled pilot trial. Int Immunopharmacol. 2016 Oct;39:314-319. https://pubmed.ncbi.nlm.nih.gov/27517517/
  119. Liu X, Li X, Li X, et al. The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren’s syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial. Clin. Rheumatol. 2018, 38, 657–664. https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01651755/full
  120. Zhang Z. Study on clinical efficacy of methotrexate combined with total glucosides of paeony in the treatment of rheumatoid arthritis. Chin J Urban Rural Enterp Hyg, 2010, 3:24–25
  121. Ma J. Study on clinical efficacy of methotrexate combined with total glucosides of paeony in treating rheumatoid arthritis. Jilin Med J, 2010, 31(28):4934–4935
  122. Shang GL, Liu JH. Comparative study on clinical efficacy of methotrexate combined with total glucosides of paeony in the treatment of rheumatoid arthritis. Chin J Clin Ration Drug Use, 2009, 2(4):1–2
  123. Liu ZY, Liu XJ, Wang ZH. Study on clinical efficacy of pafulin combined with methotrexate in the treatment of rheumatoid arthritis. Cent Plains Med J, 2007, 34(3):83–84
  124. Wang DF, Pei RX. Total glucosides of paeony treated 32 patients with rheumatoid arthritis. Shanxi J Tradit Chin Med, 2007, 28(4):421–422
  125. Shi LP, Zhu MH, He Y. Effect of total glucosides of paeony combined with leflunomide on IL-1β, IL-6 and TNF-α in rheumatoid arthritis. Chin J Pract Med. 2011;38(3):1–3.
  126. Wang YP. Therapeutic effect and comparison of liver damage of two combined schemes on rheumatoid arthritis. Public Medical Forum Magazine. 2012;16(13):1644–1646.
  127. Zheng HM, Jue HY, Yang YH. Effects of total glucosides of paeony on lipid profile in patients with rheumatoid arthritis. Chin J Basic Med Traditional Chin Med. 2014;20(06):832–834.
  128. Wang Y. Effect of combination of total glucosides of paeony and immunosuppressive on transaminase in treatment of rheumatoid arthritis. J Clin Med Lit. 2015;2(11):2132.
  129. Zhu XX. Clinical study on the effect of Huangqijianzhong decoction for patients with MDR-TB. Chin J Curr Traditional West Med. 2004;2:526–527.
  130. Zhang J, Zhang Y, Liang HW. Clinical study on the effect of Kanglao decoction for patients with MDR-TB. J Clin Pulm Med. 2011;16:1459–1460.
  131. Chen FY, Mei MX. Clinical observation of Jianpirunfei pill combined with BCG vaccine for 72 patients with MDR-TB. Guide China Med. 2010;8:87–88.
  132. Zhao YH, Zhang ZX, Du Y. Therapeutic effects of containing DPC or PAS regimens on multidrug-resistant pulmonary tuberculosis. Chin J Antituberc. 2001;23:27–29.
  133. Ghodke-Puranik Y, Thorn CF, et al. Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2013 Apr;23(4):236-41. https://pubmed.ncbi.nlm.nih.gov/23407051/
 

דוגמא למונוגרף מלא

לרכישת מנוי  |  כניסת מנויים

בחזרה לדף הראשי של האינדקס

חזרה לתחילת העמוד

חזרה לעמוד הקודם